# Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma

> **NCT00980473** · PHASE3 · UNKNOWN · sponsor: **Singapore National Eye Centre** · enrollment: 80 (estimated)

## Conditions studied

- Glaucoma

## Interventions

- **PROCEDURE:** Argon Laser Iridoplasty
- **DRUG:** Travatan/ Timolol/Azopt

## Key facts

- **NCT ID:** NCT00980473
- **Lead sponsor:** Singapore National Eye Centre
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-09
- **Primary completion:** 2011-09
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2011-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00980473

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00980473, "Argon Laser Peripheral Iridoplasty for Primary Angle Closure Glaucoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00980473. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*